Clinical Trials Logo
  1. Home
  2. Coronary Artery Disease
  3. NCT00812552
  4. Details
NCT00812552 Clinical Trial

Drug Eluting Stent Registry of Thrombosis

Coronary Artery Disease Clinical Trial

— DESERT  

Official title:
Drug Eluting Stent Registry of Thrombosis

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00812552
Other study ID # DESERT
Secondary ID
Status Completed
Phase N/A
First received December 18, 2008
Last updated April 22, 2013
Start date September 2009
Est. completion date May 2012

Study information
Verified date April 2013
Source Medstar Research Institute
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

Multicenter, case-control study, to collect data regarding incidences of late and very late drug-eluting stent thrombosis with the aim of identifying trends and possible correlates of stent thrombosis.

Recruitment information / eligibility
Status Completed
Enrollment 984
Est. completion date May 2012
Est. primary completion date May 2012
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients over 18 years of age

- Case Subjects: patients who have experienced definite late or very late drug-eluting stent thrombosis

- Control Subjects: patients who underwent drug-eluting stent implantation at the same facility and in the same time period as a matched Case Subject, and have not experienced drug-eluting stent thrombosis.

Exclusion Criteria:

- Patients not meeting the above Inclusion Criteria

Study Design

Observational Model: Case Control, Time Perspective: Retrospective

Related Conditions & MeSH terms

Locations
Country Name City State
Canada Laval Hospital Quebec City Quebec
Switzerland Bern University Hospital Bern
United States Summa Health System Akron Ohio
United States Beth Israel Deaconess Medical Center Boston Massachusetts
United States New York Methodist Hospital Brooklyn New York
United States Lahey Clinic Burlington Massachusetts
United States South Carolina Heart Center, PA Columbia South Carolina
United States Geisinger Health System Danville Pennsylvania
United States Saint Luke's Hospital, Mid America Heart Institute Kansas City Missouri
United States Lexington Cardiac Research Foundation/Central Baptist Hospital Lexington Kentucky
United States Columbia University Medical Center New York New York
United States Maine Medical Center Portland Maine
United States The Miriam Hospital Providence Rhode Island
United States The Valley Hospital Ridgewood New Jersey
United States Mercy General Hospital / Mercy Heart and Vascular Institute Cardiovascular Research Sacramento California
United States Prairie Education and Research Cooperative Springfield Illinois
United States Washington Adventist Hospital Takoma Park Maryland
United States Washington Hospital Center Washington District of Columbia
United States Winchester Medical Center Winchester Virginia
United States Wake Forest University Baptist Medical Center Winston-Salem North Carolina

Sponsors (1)
Lead Sponsor Collaborator
Medstar Research Institute

Countries where clinical trial is conducted

United States,  Canada,  Switzerland, 

Outcome
Type Measure Description Time frame Safety issue
Primary To assess for potential correlates surrounding subjects and lesions among patients that experience late or very late drug-eluting stent thrombosis Baseline No
See also
  Status Clinical Trial Phase
Recruiting NCT06030596 - SPECT Myocardial Blood Flow Quantification for Diagnosis of Ischemic Heart Disease Determined by Fraction Flow Reserve
Completed NCT04080700 - Korean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA)
Recruiting NCT03810599 - Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study N/A
Recruiting NCT06002932 - Comparison of PROVISIONal 1-stent Strategy With DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions. N/A
Not yet recruiting NCT06032572 - Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE) N/A
Recruiting NCT04242134 - Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions N/A
Recruiting NCT05308719 - Nasal Oxygen Therapy After Cardiac Surgery N/A
Completed NCT04556994 - Phase 1 Cardiac Rehabilitation With and Without Lower Limb Paddling Effects in Post CABG Patients. N/A
Recruiting NCT05846893 - Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease N/A
Recruiting NCT06027788 - CTSN Embolic Protection Trial N/A
Recruiting NCT05023629 - STunning After Balloon Occlusion N/A
Completed NCT04941560 - Assessing the Association Between Multi-dimension Facial Characteristics and Coronary Artery Diseases
Completed NCT04006288 - Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease Phase 4
Completed NCT01860274 - Meshed Vein Graft Patency Trial - VEST N/A
Recruiting NCT06174090 - The Effect of Video Education on Pain, Anxiety and Knowledge Levels of Coronary Bypass Graft Surgery Patients N/A
Completed NCT03968809 - Role of Cardioflux in Predicting Coronary Artery Disease (CAD) Outcomes
Terminated NCT03959072 - Cardiac Cath Lab Staff Radiation Exposure
Recruiting NCT04566497 - Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up. N/A
Recruiting NCT05065073 - Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography Phase 4
Completed NCT05096442 - Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions N/A